While sales have grown, profit growth shows a concerning trend. Compounded Sales Growth (TTM) is at 15%. However, Compounded Profit Growth (TTM) is -4%. Quarterly OPM decreased from 19.03% in Mar 2023 to 17.58% in Mar 2024. Annual OPM also declined from 17.25% in Mar 2023 to 15.66% in Mar 2024. Net profit also decreased from 3.56 in Mar 2023 to 3.43 in Mar 2024.

This mixed performance suggests that while the company is expanding its sales, it is struggling to maintain profitability. The decline in both quarterly and annual OPM further indicates potential challenges in managing expenses and maintaining operational efficiency.

The company demonstrates strong capital efficiency and returns. ROCE is 25.62%. ROE is 19%. These figures suggest that the company is effectively utilizing its capital to generate returns for its investors.

These high returns on capital and equity reflect positively on the management's ability to allocate resources and manage the business effectively, leading to good profitability.

The company shows good financial health with improved debt management. Borrowings have decreased from ₹ 1.34 Cr. in Mar 2023 to ₹ 0.00 Cr. in Mar 2024. This indicates a positive step towards reducing financial leverage and strengthening the company's balance sheet.

This improved debt management enhances the company's resilience and reduces its vulnerability to financial risks.

Working capital management shows signs of inefficiency. The Cash Conversion Cycle has increased from 163.98 days in Mar 2023 to 190.85 days in Mar 2024. Inventory Days have also increased from 107.26 days to 132.52 days. This indicates that the company is taking longer to convert its investments in inventory and receivables into cash.

The increasing cash conversion cycle and inventory days suggest that the company may need to improve its operational efficiency to reduce the time it takes to convert resources into cash.

The sales and operating profit are only provided for the overall company, not by segment. The company's revenue is not broken down into different operating segments. Therefore, it is not possible to assess the volatility in each segment.

There is no data about foreign exchange or interest rate exposure. There isn't enough information to determine how much risk the company faces from changes in foreign exchange rates or interest rates.

The financial data provided does not include specific information on regulatory compliance costs. Therefore, it is not possible to evaluate trends in these costs and their potential impact on the company's financial performance.